VeriMom¿Debo evitar cannabigerol durante el embarazo? | VeriMom
No harmonised (Annex VI CLP) reproductive classification for cannabigerol (CBG) was identified; ECHA InfoCard shows company C&L notifications reporting H361d but this appears to come from C&L notifications rather than a legally harmonised CLH entry, and there are no CIR or SCCS safety opinions specific to CBG. Cannabinoids as a class (e.g., THC/CBD) have been associated with developmental effects in animal and human studies, giving a plausible class-based mechanism, but direct reproductive/teratogenic data for CBG are lacking; dermal absorption is plausible and likely low-but-measurable for a small lipophilic phytocannabinoid. (See ECHA InfoCard; PubChem; human/animal cannabinoid developmental reviews.).
ECHA regulatory hazard statements
- •H361D
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- ¿Es cannabigerol seguro durante el embarazo?
- No harmonised (Annex VI CLP) reproductive classification for cannabigerol (CBG) was identified; ECHA InfoCard shows company C&L notifications reporting H361d but this appears to come from C&L notifications rather than a legally harmonised CLH entry, and there are no CIR or SCCS safety opinions specific to CBG. Cannabinoids as a class (e.g., THC/CBD) have been associated with developmental effects in animal and human studies, giving a plausible class-based mechanism, but direct reproductive/teratogenic data for CBG are lacking; dermal absorption is plausible and likely low-but-measurable for a small lipophilic phytocannabinoid. (See ECHA InfoCard; PubChem; human/animal cannabinoid developmental reviews.).
- ¿Es cannabigerol seguro durante la lactancia?
- There are no authoritative safety assessments (CIR/SCCS/harmonised CLP) specifically identifying CBG as a confirmed reproductive or lactation hazard. Cannabinoids can be transferred to milk (class concern from THC/CBD literature) so a theoretical class-based mechanism exists, but direct studies on CBG transfer in human milk or lactation-specific toxicity are not found; topical cosmetic use would give low but measurable maternal systemic exposure in some scenarios, so breastfeeding exposure is possible but not characterized for CBG.
- ¿Es cannabigerol seguro para la piel del bebé?
- No infant-specific toxicity or safety data for topical CBG were identified. By class-based analogy to other cannabinoids there is a theoretical mechanism, but no direct evidence that CBG causes reproductive/infant toxicity. Because infant skin has higher absorption per kg, exposure score is increased by +1 compared with adults when measurable dermal absorption is plausible; direct dermal absorption studies for CBG were not found.
- ¿Cómo puntúa VeriMom a cannabigerol?
- VeriMom puntúa cannabigerol en 27/100 (riesgo alto) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a cannabigerol en el embarazo?
- Consulta nuestra lista de alternativas seguras a cannabigerol según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.